Carson Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Carson Advisory's LLY Position: Q2 2026 in Review
Carson Advisory increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $15.3K and bringing the position to 796 shares worth $955K. The position accounts for 0.44% of the portfolio, ranked #55.
Carson Advisory first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Carson Advisory held 796 shares of Eli Lilly worth $955K as of Q2 2026.
- Carson Advisory bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
- Eli Lilly made up 0.44% of Carson Advisory's portfolio in Q2 2026, its #55 holding.
- Carson Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Carson Advisory's 13F filing for Q2 2026, filed 11 Aug 2026.